Tolnaftate

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Tolnaftate
Generic name: TOLNAFTATE 1%
Manufacturer: Trifecta Pharmaceuticals USA, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 091b907f-544a-86c9-e063-6294a90a5d87
SPL ID: 2a923ecc-8dad-73b1-e063-6394a90a7022
Version: 2
Effective date: 2024-12-31
Source export date: 2026-10-30
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/a3e33fe073aa0aa94eb690c6684c74434c63cebfbf7c5530205a2c3e957ecb8b/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:39:27

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Tolnaftate	openfda.brand_name
generic name		TOLNAFTATE 1%	openfda.generic_name
manufacturer name		Trifecta Pharmaceuticals USA, LLC	openfda.manufacturer_name
ndc	package	69396-130-01	openfda.package_ndc
ndc	product	69396-130	openfda.product_ndc
ndc11	package	69396013001	derived:openfda.package_ndc
rxcui		103951	openfda.rxcui
spl id		2a923ecc-8dad-73b1-e063-6394a90a7022	id
spl set id		091b907f-544a-86c9-e063-6294a90a5d87	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. When using this product avoid contact with the eyes. Stop use and ask a doctor if ● irritation occurs ● there is no improvement within 4 weeks Do not use on children under 2 years of age except under the advice and supervision of a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.